Investigating Organ Toxicity Profile of Tenofovir and Tenofovir Nanoparticle on the Liver and Kidney : Experimental Animal Study :Experimental Animal Study

Aniekan Imo Peter; Edwin CS Naidu; Edidiong Akang; Oluwatosin O Ogedengbe; Ugochukwu Offor; Sanjeev Rambharose; Rahul Kalhapure; Anil Chuturgoon; Thirumala Govender; Onyemaechi O Azu

추천

검색

질문

자료유형: 학술저널

저자정보: Aniekan Imo Peter (University of KwaZulu-Natal) Edwin CS Naidu (University of KwaZulu-Natal) Edidiong Akang (University of KwaZulu-Natal) Oluwatosin O Ogedengbe (University of KwaZulu-Natal) Ugochukwu Offor (University of KwaZulu-Natal) Sanjeev Rambharose (University of KwaZulu-Natal) Rahul Kalhapure (University of KwaZulu-Natal) Anil Chuturgoon (University of KwaZulu-Natal) Thirumala Govender (University of KwaZulu-Natal) Onyemaechi O Azu (University of KwaZulu-Natal)

저널정보: 한국독성학회 Toxicological Research Toxicological Research Vol.34 No.3

발행연도: 2018.7

수록면: 221 - 229 (9page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Tenofovir nanoparticles are novel therapeutic intervention in human immunodeficiency virus (HIV) infection reaching the virus in their sanctuary sites. However, there has been no systemic toxicity testing of this formulation despite global concerns on the safety of nano drugs. Therefore, this study was designed to investigate the toxicity of Tenofovir nanoparticle (NTDF) on the liver and kidney using an animal model. Fifteen adult male Sprague-Dawley (SD) rats maintained at the animal house of the biomedical resources unit of the University of KwaZulu-Natal were weighed and divided into three groups. Control animals (A) were administered with normal saline (NS). The therapeutic doses of Tenofovir (TDF) and nanoparticles of Tenofovir (NTDF) were administered to group B and C and observed for signs of stress for four weeks after which animals were weighed and sacrificed. Liver and kidney were removed and fixed in formal saline, processed and stained using H/E, PAS and MT stains for light microscopy. Serum was obtained for renal function test (RFT) and liver function test (LFT). Cellular measurements and capturing were done using ImageJ and Leica software 2.0. Data were analysed using graph pad 6, p values ＜ 0.05 were significant. We observed no signs of behavioural toxicity and no mortality during this study, however, in the kidneys, we reported mild morphological perturbations widening of Bowman’s space, and vacuolations in glomerulus and tubules of TDF and NTDF animals. Also, there was a significant elevation of glycogen deposition in NTDF and TDF animals when compared with control. In the liver, there were mild histological changes with widening of sinusoidal spaces, vacuolations in hepatocytes and elevation of glycogen deposition in TDF and NTDF administered animals. In addition to this, there were no significant differences in stereological measurements and cell count, LFT, RFT, weight changes and organo-somatic index between treatment groups and control. In conclusion, NTDF and TDF in therapeutic doses can lead to mild hepatic and renal histological damage. Further studies are needed to understand the precise genetic mechanism.

#Tenofovir nanoparticles #Liver #Kidney #Histology

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!